top of page

OUR JOURNEY

_edited.jpg

FROM VISION TO VISUALIZATION

OUR STORY

Power. Precision. Innovation. Ingenuity.

Stellaromics was founded in 2022 by a team of world renowned scientists on a mission to move biomedical research forward faster. The Plexa suite of products was developed to extend their progress by empowering others to innovate alongside them. With Plexa, any researcher or clinician can create fully annotated cellular maps for clearer understanding of disease progression and response to therapy.

About1.png

Our Journey So Far

2018

STARmap IS DEVELOPED

Stellaromics founders patent a novel technology for identifying high resolution 3D transcription patterns in native biological tissue using hydrogel tissue chemistry.

2022

STELLAROMICS IS LAUNCHED

Scientists, operators and investors come together to extend the value of STARmap technology, developing a product suite to empower biomedical innovation worldwide.

End of 2022

PRE-SALE FOR PLEXA IN SITU ANALYZER

Now, all types of researchers can pre-order the first Stellaromics product, Plexa In Situ Analyzer. Sign up for updates regarding the Plexa launch and early access.

Plexa starter reagent kit available now to be tested in your favorite tissues. 

A Stellar Team

The Stellaromics leadership team brings with it decades of successful scientific innovation, and a passion to advance life sciences research and improve healthcare around the world.

Image by Greg Rakozy
bottom of page